Gall Bladder Cancer Clinical Trials

A listing of Gall Bladder Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 45 clinical trials
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC)

Study consists of an open-label, safety run-in part and a randomized, double-blind, placebo-controlled Phase 2/3 part. In the Phase 2/3 part, the study will evaluate whether bintrafusp alfa in combination with the current standard of care (SoC) (gemcitabine plus cisplatin) improves overall survival (OS) in chemotherapy and immunotherapy-nave participants with …

kidney function tests
cancer
measurable disease
antivirals
bintrafusp alfa
  • 173 views
  • 05 May, 2021
  • 126 locations
A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers

, inoperable and advanced or metastatic biliary tract cancer (BTC), including intra-hepatic cholangiocarcinoma (ICC), extra-hepatic cholangiocarcinoma (ECC), and gallbladder cancer (GBC).

  • 0 views
  • 16 May, 2021
  • 46 locations
A Study to Evaluate Safety Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients

toxicity. The patients with advanced melanoma, uveal melanoma, cholangiocarcinoma, gallbladder cancer, ER+ breast, gastric, ovarian, pancreatic, colorectal, liver or anaplastic thyroid cancer who

measurable disease
primary cancer
breast cancer
bone marrow procedure
platelet count
  • 4 views
  • 01 Aug, 2021
  • 12 locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

tumors) (closed to accrual) Clear cell endometrial cancer Clear cell ovarian cancer (closed to accrual) Gestational trophoblastic disease (GTD) Gallbladder cancer

octreotide
ovarian cancer
carcinoma lung
neuroendocrine carcinoma
autoimmune disease
  • 6047 views
  • 01 Aug, 2021
  • 815 locations
Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms

The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Gallbladder Neoplasms.

anticoagulants
platelet count
gallbladder neoplasms
  • 36 views
  • 23 Jan, 2021
  • 1 location
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients with stage II-III gallbladder cancer

  • 0 views
  • 27 Jan, 2021
  • 1 location
The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer

The extent of hepatic resection for gallbladder cancer can be done from a wedge resection to 4b/5 bisegmentectomy. This study aims to compare the recurrence rates and survival rates between

  • 32 views
  • 21 Jan, 2021
  • 1 location
Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancers

benefit with combination chemotherapy in gallbladder cancers. Gallbladder cancer is not common western world and thus there is lack of evidence regarding the impact of neoadjuvant or concurrent chemo

combination chemotherapy
gallbladder disease
serum bilirubin
residual disease
jaundice
  • 38 views
  • 22 Jan, 2021
  • 1 location
Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration

This is an open label study for any patients with a bile duct cancer or gallbladder cancer, who will be treated with gemcitabine and cisplatin chemotherapy (the ABC02 regime). Patients recruited

renal function
cancer
akynzeo
cholangiocarcinoma
gemcitabine
  • 0 views
  • 13 Mar, 2021
  • 1 location
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

The purpose of this study is to evaluate the feasibility, efficacy and safety of target therapy according to genomic and proteomic profiling combined with FORFIRINOX in advanced or recurrent extrahepatic cholangiocarcinoma and gallbladder carcinoma.

gallbladder carcinoma
cholangiocarcinoma
mates
tyrosine
carcinoma
  • 14 views
  • 22 Jan, 2021
  • 1 location